Home > Subject >

Drug treatment

A New Approach to the Care of Hospitalized Patients with Type 2 Diabetes

Stanley Schwartz, M.D., F.A.C.P., F.A.C.E., and Ralph A. DeFronzo, M.D.
Volume 32, Number 1, pages 10–18

AIM-HIGH Misses Its Target

Charles A. Reasner, M.D.
Volume 30, Number 3, pages 29-30

Basal-Bolus Insulin Therapy

Geralyn R. Spollett, M.S.N., A.N.P., C.D.E.
Volume 21, Number 1, pages 33-36

Benefits of Pramlintide for Insulin-Using Patients

Dale Hamilton, M.D., Saundra Hendricks, M.S., A.P.R.N., Brandon Walsh, Ph.D., and Ken Wilhelm, M.D.
Volume 26, Number 4, pages 6-13

Beta-Blockers in the Diabetic Patient

David S.H. Bell, M.B., F.A.C.E.
Volume 22, Number 1, pages 20-23

Beyond Glycemic Control

Nandish Thurkal, M.D., Edward Bergen, D.O., Shailesh Nandish, M.D., Mike Lujan, B.S., Rene Oliveros, M.D., F.A.C.C., and Robert Chilton, D.O., F.A.C.C.
Volume 29, Number 1, pages 13-16

Clinical Controversies in Diabetes: Sulfonylureas and Postprandial Glucose Control

Silvio E. Inzucchi, M.D.
Volume 21, Number 4, pages 33-35

Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes

American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, and North American Association for the Study of Obesity
Volume 24, Number 1, pages 27-36

Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections

Eugenia Caternor, M.S.N., F.N.P.-C., Debbie Griffin, M.S.N., F.N.P.-C., and Cherie Howk, Ph.D., F.N.P.-B.C.
Volume 31, Number 3, pages 16–21

Cutting Edge Versus Cutting Cost

David S. H. Bell, M.D., Professor Emeritus, Department of Medicine, University of Alabama Birmingham
Volume 35, Number 4, pages 12-16

Cycloset's Long Road

Charles A. Reasner, M.D.
Volume 28, Number 4, pages 29-30

Direct Renin Inhibition

Curtis Triplitt, Pharm.D., C.D.E., and Shay L. Reichert, Pharm.D., B.C.P.S., C.D.E.
Volume 28, Number 1, pages 6-15

Do Antidiabetic Drugs Using the Incretin Pathway Cause Pancreatitis?

Leann Olansky, M.D.
Volume 30, Number 4, pages 22-25

Do Statins Cause Diabetes?

Charles A. Reasner, M.D.
Volume 30, Number 4, pages 28-29

Emerging Technologies in Rapid-Acting Prandial Insulin

David C. Klonoff, M.D., F.A.C.P., Fellow AIMBE
Volume 33, Number 3, pages 13-18

Exenatide

Candis M. Morello, Pharm.D., C.D.E., and Steven V. Edelman, M.D.
Volume 25, Number 1, pages 6-18

Exenatide Use in Real Life

Melissa K. Cavaghan, M.D.
Volume 26, Number 4, pages 22-27

Exenatide Versus Liraglutide


Volume 33, Number 2, pages 20-21

Fixed Dose Combinations (FDCs): From Orals to Injectables

Kathleen Wyne, M.D., Ph.D.
Volume 36, Number 1, pages 15-17

Fracture as a Consequence of Thiazolidinedione Treatment in Type 2 Diabetes

Larry J. Suva, Ph.D., and Ruth L. Thomas, M.D.
Volume 26, Number 3, pages 14-21

Happy Birthday, Metformin

Charles A. Reasner, M.D.
Volume 26, Number 2, pages 34-35

Heart effects of insulin and fish oil


Volume 33, Number 1, pages 24

How to Choose Diabetes Drugs Wisely

Elena A. Christofides, M.D., FACE CEO/Owner, Endocrinology Associates, Inc. Adjunct Assistant Professor and Clinical Associate Professor, Ohio State University College of Medicine
Volume 35, Number 3, pages 10-15

How to Use Insulin in Type 2 Diabetes Mellitus

Ioana Fat, M.D., Simona Ioja, M.D., and Nancy J. Rennert, M.D., F.A.C.E., F.A.C.P.
Volume 30, Number 3, pages 17-24

Hypoglycemia in Elderly Patients Treated With Oral Agents

George E. Dailey III, M.D.
Volume 21, Number 2, pages 7-14

Increased Risk of Cancer with Insulin Glargine

Charles A. Reasner, M.D.
Volume 28, Number 3, pages 24-27

Incretin Mimetics in the Treatment of Type 2 Diabetes

David Kendall, M.D., Sherry Martin, M.D., and Dennis Kim, M.D.
Volume 23, Number 3, pages 20-27

Insulin Analog Mixes in the Management of Type 2 Diabetes Mellitus

Arturo R. Rolla, M.D.
Volume 21, Number 4, pages 36-43

Insulin Injection Technique for Adults and Children with Diabetes

Nadia Shaikh, Pharm.D., Jennifer Goldman-Levine, Pharm.D., C.D.E, B.C.-A.D.M., F.C.C.P
Volume 33, Number 3, pages 19-21

Insulin Pump Therapy in Children and Adolescents

Jean Corrigan, R.N., B.S.N., M.A., C.D.E.
Volume 28, Number 3, pages 17-24

Insulin Pumps for Type 2 Diabetes—A Useful Tool?

Katherine Pereira, M.S.N., F.N.P.-B.C., A.D.M.-B.C.
Volume 30, Number 1, pages 26-27

Insulin Resistance and Vascular Dysfunction

Eugenio Cersosimo, M.D.
Volume 27, Number 2, pages 12-16

Insulin Therapy: New Options

Jennifer Elliott, PharmD, CDE; Sara (Mandy) Reece, PharmD, CDE, BC-ADM
Volume 34, Number 4, pages 15–17

Insulin-Delivery Systems for the Management of Diabetes

Robert E. Ratner, M.D.
Volume 23, Number 1, pages 14-24

Insulin-Therapy Resistance

Glory Koerbel, R.N., M.S.N., C.D.E., and Mary Korytkowski, M.D.
Volume 22, Number 2, pages 36-40

Investment Advice

Charles A. Reasner, M.D.
Volume 26, Number 4, pages 34

Learning to Use Pramlintide

Diane M. Karl, M.D.
Volume 25, Number 1, pages 42-46

Management of Neonatal Diabetes Mellitus in a 1-Month-Old Male

Lauren Pankratz, M.D., Carisse Orsi, M.D., Chandra Slusser, and Jane Lynch, M.D.
Volume 29, Number 2, pages 4-10

Managing Diabetic Dyslipidemia

Peter P. Toth, M.D., Ph.D., F.A.A.F.P., F.N.L.A., F.C.C.P., F.A.H.A., F.A.C.C.
Volume 29, Number 1, pages 18-25

Metformin or Thiazolidinediones as First-Line Therapy in Type 2 Diabetes?

Silvio E. Inzucchi, M.D.
Volume 21, Number 3, pages 7-12

Metformin-Suppressible Primary Hyperaldosteronism

Alan Sacerdote, M.D., F.A.C.P., Mark L'Epplatanier, R.P.A., Alireza Toossi, M.D., Gul Bahtiyar, M.D., and Emad Girgis, M.D.
Volume 25, Number 4, pages 37-39

Metformin: A lifesaver for those with and without diabetes

David S. H. Bell, MB, Southside Endocrinology, Mountain Brook, Alabama
Volume 35, Number 1, pages 16-17

Modifying Insulin Resistance to Prevent Stroke

Karla Martinez, M.D., Silvio E. Inzucchi, M.D., Catherine Viscoli, Ph.D., and Walter N. Kernan, M.D.
Volume 26, Number 2, pages 19-23

Nateglinide

Priscilla A. Hollander, M.D., and James E. Foley, Ph.D.
Volume 20, Number 3, pages 24-28

NCEP ATP III Guidelines

Charles M. Alexander, M.D., Suzanne Antonello, C.T.(A.S.C.P.), Christine Heggan, B.S., and Robert A. Calder, M.D.
Volume 21, Number 1, pages 21-28

Needles: The Sticky Details

Jennifer Elliott, Pharm.D., C.D.E., Sara Reece, Pharm.D., C.D.E., B.C.-A.D.M.
Volume 34, Number 2, pages 7-11

New Additions to Our Tool Chest

Daniel L. Lorber, M.D.
Volume 25, Number 1, pages 54-55

New Directions in Diabetes Management

Elizabeth A. Stephens, M.D., Terri Ryan-Turek, R.D., C.D.E., and Juan P. Frias, M.D.
Volume 23, Number 1, pages 7-13

New Insulin Analogs

James R. LaSalle, D.O.
Volume 25, Number 3, pages 34-44

New Insulin Therapies for the Management of Diabetes Mellitus

Anna Kissin, M.D., and Harvey L. Katzeff, M.D.
Volume 21, Number 1, pages 14-20

Pathophysiology and Complications of Type 2 Diabetes

Derek D. Mafong, M.D., and Robert R. Henry, M.D.
Volume 28, Number 4, pages 13-26

Peril Seen in Diabetes Drug

Daniel L. Lorber, M.D.
Volume 21, Number 3, pages 33-34

Pharmacologic Treatment of Prediabetes

Katia Cristina Portero McLellan, Ph.D., Kathleen Wyne, M.D., Ph.D., F.A.C.E., Evangelina Trejo Villagomez, Ph.D., And Willa A. Hsueh, M.D.
Volume 33, Number 2, pages 6-11

Pioglitazone for Diabetes Prevention?

Charles A. Reasner, M.D.
Volume 30, Number 2, pages 26

Polypharmacy: What It Is and How to Manage It

Gretchen I. Riker, Pharm,D., C.G.P.
Volume 33, Number 4, pages 18-22

Position Statement: Insulin Administration

American Diabetes Association
Volume 21, Number 4, pages 14-21

Psychological Insulin Resistance

Mark Peyrot, Ph.D.
Volume 23, Number 2, pages 6-11

Renin-Angiotensin-Aldosterone System Blockers for Patients With Diabetes

Richa Gopal, M.D., M. James Lenhard, M.D., F.A.C.E., F.A.C.P., and Raelene E. Maser, Ph.D., M.T.(A.S.C.P.)
Volume 30, Number 1, pages 14-24

Rethinking Metformin

Daniel L. Lorber, M.D.
Volume 24, Number 3, pages 22-25

SGLT-2 Inhibitors and DKA

Heather Saran and Kathleen Wyne, M.D., Ph.D.
Volume 32, Number 2, pages 12-14

SGLT-2 Inhibitors and Glucose Homeostasis

Kathleen Wyne, M.D., Ph.D.
Volume 35, Number 3, pages 16-19

Should SGLT2 Inhibitors Be Used to Treat Type 1 Diabetes?

Kathleen Wyne, MD, PhD, Associate Professor, Division of Endocrinology, Diabetes and Metabolism The Ohio State University, Wexner Medical Center Columbus, Ohio
Volume 36, Number 3, pages 2-6

Should We Use Statins to Lower C-reactive Protein?—Lessons From JUPITER and AURORA

Charles A. Reasner, M.D.
Volume 28, Number 2, pages 24-25

Simplified Insulin Chart for Intensive Insulin Therapy

Terri Ryan, R.D., C.D.E.
Volume 31, Number 3, pages 10–15

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Type 2 Diabetes

Muhammad A. Abdul-Ghani, M.D., Ph.D., and Ralph A. DeFronzo, M.D.
Volume 30, Number 2, pages 6-14

Statin-induced Diabetes: Risks, Benefits and Clinical Results

David S. H. Bell, M.D., Professor Emeritus, Department of Medicine, University of Alabama Birmingham
Volume 35, Number 5, pages 16-19

Strategies for Describing Gliptins

Virginia Peragallo-Dittko, R.N., B.C.-A.D.M., C.D.E.
Volume 28, Number 4, pages 27-29

Sulfonylureas

Diane M. Karl, M.D.
Volume 23, Number 1, pages 26-29

Symlin and Byetta – Two New Antihyperglycemic Medications

Davida Kruger, M.S.N., A.P.R.N.-B.C., B.C.-A.D.M.
Volume 25, Number 1, pages 49-52

The Avandia Flap

Charles A. Reasner, M.D.
Volume 26, Number 3, pages 35-36

The Cadillac Combination for Type 2 Diabetes: A GLP-1 receptor Agonist and a SGLT2 Inhibitor

David S. H. Bell, MB, FACE, FACP Professor of Medicine (retired) University of Alabama and Southside Endocrinology Birmingham, Alabama, and Edison Goncalves, MD, FACE, FACP Diabetes and Thyroid Associates Birmingham, Alabama
Volume 36, Number 3, pages 10-13

The Case for Exenatide as a Treatment Option Before Insulin in Patients with Type 2 Diabetes

Robert R. Henry, M.D., Brandon Walsh, Ph.D., John H. Holcombe, M.D., and Ted Okerson, M.D.
Volume 27, Number 4, pages 14-20

The New Insulin Analogs

Alison B. Evert, R.D., C.D.E., and Richard S. Mauseth, M.D.
Volume 23, Number 2, pages 28-37

The Vytorin Controversy

Charles A. Reasner
Volume 27, Number 1, pages 8-9

Use of Bile Acid Sequestrants to Treat Type 2 Diabetes

Charles A. Reasner, M.D.
Volume 28, Number 2, pages 6-15

Use of Rapid-Acting Insulin Analogs During Pregnancy

SARA (MANDY) WILSON REECE, PHARM.D., C.D.E., B.C.-A.D.M., ALEXANDER KANOPKA, PHARM.D. CANDIDATE, AND IANA MERVIN, PHARM.D. CANDIDATE
Volume 33, Number 1, pages 12-14

Using Sulfonylureas in Patients with Renal Insufficiency

Kendall M. Campbell, M.D., and James R. Taylor, Pharm.D., C.D.E.
Volume 27, Number 4, pages 21-24

Variations on Metformin: "Glucohelp or Glucohype"?

William L. Isley, M.D., and Charles A. Reasner, M.D.
Volume 20, Number 3, pages 30-33